The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery
Open accessAbstract
Although there is no spontaneous regeneration of mammalian spinal axons after injury, they can be enticed to grow if cAMP is elevated in the neuronal cell bodies before the spinal axons are cut. Prophylactic injection of cAMP, however, is useless as therapy for spinal injuries. We now show that the phosphodiesterase 4 (PDE4) inhibitor rolipram (which readily crosses the blood–brain barrier) overcomes inhibitors of regeneration in myelin in culture and promotes regeneration in vivo . Two weeks after a hemisection lesion at C3/4, with embryonic spinal tissue implanted immediately at the lesion site, a 10-day delivery of rolipram results in considerable axon regrowth into the transplant and a significant improvement in motor function. Surprisingly, in rolipram-treated animals, there was also an attenuation of reactive gliosis. Hence, because rolipram promotes axon regeneration, attenuates the formation of the glial scar, and significantly enhances functional recovery, and because it is effective when delivered s.c., as well as post-injury, it is a strong candidate as a useful therapy subsequent to spinal cord injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Degeneration and regeneration of axons in the lesioned spinal cord
Schwab, M. E., & Bartholdi, D. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.2.319 · Cited by 1,118
Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration
Fournier, A. E., GrandPre, T., & Strittmatter, S. M. (2001) · Nature · doi:10.1038/35053072 · Cited by 1,080
A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration
Mukhopadhyay, G., Doherty, P., Walsh, F. S., Crocker, P. R., & Filbin, M. T. (1994) · Neuron · doi:10.1016/0896-6273(94)90042-6 · Cited by 1,061
Self-citationOligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth
Wang, K. C., Koprivica, V., Kim, J. A., Sivasankaran, R., Guo, Y., Neve, R. L., & He, Z. (2002) · Nature · doi:10.1038/nature00867 · Cited by 955
Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS
Filbin, M. T. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1195 · Cited by 871
Self-citationSpinal Axon Regeneration Induced by Elevation of Cyclic AMP
Qiu, J., Cai, D., Dai, H., McAtee, M., Hoffman, P. N., Bregman, B. S., & Filbin, M. T. (2002) · Neuron · doi:10.1016/s0896-6273(02)00730-4 · Cited by 671
Self-citationMyelin-Associated Glycoprotein Interacts with the Nogo66 Receptor to Inhibit Neurite Outgrowth
Domeniconi, M., Cao, Z., Spencer, T., Sivasankaran, R., Wang, K. C., Nikulina, E., Kimura, N., Cai, H., Deng, K., Gao, Y., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00770-5 · Cited by 593
Self-citationMyelin-Associated Glycoprotein as a Functional Ligand for the Nogo-66 Receptor
Liu, B. P., Fournier, A., GrandPré, T., & Strittmatter, S. M. (2002) · Science · doi:10.1126/science.1073031 · Cited by 577
Bach, M. E., Barad, M., Son, H., Zhuo, M., Lu, Y.-F., Shih, R., Mansuy, I., Hawkins, R. D., & Kandel, E. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5280 · Cited by 560
Neumann, S., Bradke, F., Tessier-Lavigne, M., & Basbaum, A. I. (2002) · Neuron · doi:10.1016/s0896-6273(02)00702-x · Cited by 558
Cited by
Therapeutic interventions after spinal cord injury
Thuret, S., Moon, L. D. F., & Gage, F. H. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1955 · Cited by 1,012
Lugnier, C. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.07.003 · Cited by 870
From basics to clinical: A comprehensive review on spinal cord injury
Silva, N. A., Sousa, N., Reis, R. L., & Salgado, A. J. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.11.002 · Cited by 814
Keynote review: Phosphodiesterase-4 as a therapeutic target
Houslay, M. D., Schafer, P., & Zhang, K. Y. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03622-6 · Cited by 635
The DISC locus in psychiatric illness
Chubb, J. E., Bradshaw, N. J., Soares, D. C., Porteous, D. J., & Millar, J. K. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002106 · Cited by 542
Metadata
- Authors
- Nikulina, E., Tidwell, J. L., Dai, H. N., Bregman, B. S., & Filbin, M. T.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2004-06
- Volume
- 101
- Issue
- 23
- Pages
- 8786-8790
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2135315011
- Cited by
- 345
- References
- 32
- FWCI
- 9.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. https://app.cochat.ai/papers/10.1073/pnas.0402595101
- The paper
- Nikulina, E., Tidwell, J. L., Dai, H. N., Bregman, B. S., & Filbin, M. T. (2004). The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0402595101
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.